CNA Financial heads into its August 3 Q3 earnings report with options traders still leaning defensive — and a Q2 result already in hand that briefly lifted the stock before a sharp reversal.
The options signal remains the clearest positioning read into this print. The put/call ratio has eased slightly to 0.48 from the 0.49 level flagged ahead of the July 27 Q2 release, but it remains about one standard deviation above its 20-day average of 0.38. That's a notable shift from the sub-0.30 readings that prevailed through June and into mid-July. The stock itself jumped 3.1% on the day of the Q2 print, then gave back those gains almost entirely — closing Thursday down 3.4% to $53.26. On the week, CNA is still up roughly 2%, and the one-month gain holds near 9%, so the hedging activity again looks more like protection on a well-performing position than an outright bearish bet.
The borrow market tells a relaxed story. Availability has tightened slightly from the 210% range seen before the Q2 print to around 190% now — still meaning there are nearly twice as many shares available to lend as there are shares currently shorted — and borrowing costs have actually fallen further, dropping 27% on the week to just 0.42%. Short interest itself remains low at 1.17% of the free float, roughly flat over the past month. Nothing in the lending market suggests meaningful conviction from the short side heading in.
The fundamental debate is narrower than the positioning might imply. The bull case rests on reserve discipline — 15.9% sequential growth in case reserves — and continued new business momentum, with new premiums up 18% despite softness in international rates. Bears point to downward pressure on EPS estimates and a valuation that looks stretched relative to the stock's own history even if it appears modest versus the broader market. Analyst coverage is thin and dated: the most recent target moves on record are from early 2025, with Keefe Bruyette holding a Market Perform at $53 and BofA Securities carrying an Underperform at $48 — a target now below the current price. Given the staleness of those figures, they offer limited guidance on where the Street stands today.
The August 3 print will test whether the Q2 beat was a turning point in CNA's underwriting margin trajectory or a one-quarter reprieve in a tougher environment — and whether the stock, having already recouped most of its post-Q1 losses, can sustain a premium to where its most skeptical analyst thinks it belongs.
See the live data behind this article on ORTEX.
Open CNA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
